These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34896815)

  • 1. High dose cannabidiol (CBD) in the treatment of new-onset refractory status epilepticus (NORSE).
    Aydemir S; Kandula P
    Seizure; 2022 Jan; 94():126-128. PubMed ID: 34896815
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabidiol in refractory status epilepticus: A review of clinical experiences.
    Duda J; Reinert JP
    Seizure; 2022 Dec; 103():115-119. PubMed ID: 36399869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabidiol oil in the treatment of super refractory status epilepticus. A case report.
    Rosemergy I; Adler J; Psirides A
    Seizure; 2016 Feb; 35():56-8. PubMed ID: 26803051
    [No Abstract]   [Full Text] [Related]  

  • 4. Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment.
    Wadayama T; Shimizu M; Yata T; Ishikura T; Kajiyama Y; Hirozawa D; Okuno T; Mochizuki H
    J Neuroimmunol; 2022 Feb; 363():577789. PubMed ID: 34973472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabidiol in the acute phase of febrile infection-related epilepsy syndrome (FIRES).
    Fetta A; Crotti E; Campostrini E; Bergonzini L; Cesaroni CA; Conti F; Di Pisa V; Gentile V; Mondardini MC; Vezzoli C; Giordano L; Cordelli DM
    Epilepsia Open; 2023 Jun; 8(2):685-691. PubMed ID: 37042946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases.
    Gofshteyn JS; Wilfong A; Devinsky O; Bluvstein J; Charuta J; Ciliberto MA; Laux L; Marsh ED
    J Child Neurol; 2017 Jan; 32(1):35-40. PubMed ID: 27655472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of potassium bromide in the treatment of drug-resistant epilepsy: a case of new-onset refractory status epilepticus].
    Takei J; Takei R; Nozuma S; Nakahara K; Watanabe O; Takashima H
    Rinsho Shinkeigaku; 2016 Nov; 56(11):759-763. PubMed ID: 27773903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myoclonic super-refractory status epilepticus with favourable evolution in a teenager with FIRES: Is the association of vagus nerve stimulation and cannabidiol effective?
    Bonardi CM; Furlanis GM; Toldo I; Guarrera B; Luisi C; Pettenazzo A; Nosadini M; Boniver C; Sartori S; Landi A
    Brain Dev; 2023 May; 45(5):293-299. PubMed ID: 36725381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
    Hirsch LJ; Gaspard N; van Baalen A; Nabbout R; Demeret S; Loddenkemper T; Navarro V; Specchio N; Lagae L; Rossetti AO; Hocker S; Gofton TE; Abend NS; Gilmore EJ; Hahn C; Khosravani H; Rosenow F; Trinka E
    Epilepsia; 2018 Apr; 59(4):739-744. PubMed ID: 29399791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-line immunotherapy in new onset refractory status epilepticus.
    Hanin A; Muscal E; Hirsch LJ
    Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort).
    Sculier C; Barcia Aguilar C; Gaspard N; Gaínza-Lein M; Sánchez Fernández I; Amengual-Gual M; Anderson A; Arya R; Burrows BT; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Gorman M; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello J; Rusie A; Sperberg K; Stredny CM; Tasker RC; Tchapyjnikov D; Vasquez A; Wainwright MS; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsia; 2021 Jul; 62(7):1629-1642. PubMed ID: 34091885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of new onset refractory status epilepticus/febrile infection-related epilepsy syndrome with tocilizumab in a child and a young adult.
    Girardin ML; Flamand T; Roignot O; Abi Warde MT; Mutschler V; Voulleminot P; Guillot M; Dinkelacker V; De Saint-Martin A
    Epilepsia; 2023 Jun; 64(6):e87-e92. PubMed ID: 36961094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-convulsive status epilepticus in the setting of cannabidiol adjunctive therapy.
    Tanwir A; Szabó CÁ
    Epileptic Disord; 2022 Aug; 24(4):713-718. PubMed ID: 35770762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tocilizumab treatment for new onset refractory status epilepticus.
    Jun JS; Lee ST; Kim R; Chu K; Lee SK
    Ann Neurol; 2018 Dec; 84(6):940-945. PubMed ID: 30408233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders.
    Golub V; Reddy DS
    Adv Exp Med Biol; 2021; 1264():93-110. PubMed ID: 33332006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New-onset refractory status epilepticus (NORSE) and febrile infection-related epilepsy syndrome (FIRES): State of the art and perspectives.
    Gaspard N; Hirsch LJ; Sculier C; Loddenkemper T; van Baalen A; Lancrenon J; Emmery M; Specchio N; Farias-Moeller R; Wong N; Nabbout R
    Epilepsia; 2018 Apr; 59(4):745-752. PubMed ID: 29476535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in Children Treated with Pentobarbital Infusion for Refractory and Super-Refractory Status Epilepticus.
    Erklauer J; Graf J; McPherson M; Anderson A; Wilfong A; Minard CG; Loftis L
    Neurocrit Care; 2018 Oct; 29(2):171-179. PubMed ID: 29582225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study on super-refractory status epilepticus from India illustrates a worldwide struggle.
    Zelano J
    Epilepsy Behav; 2021 May; 118():107934. PubMed ID: 33827759
    [No Abstract]   [Full Text] [Related]  

  • 19. Considering safety and patient tolerance in the use of ketogenic diet in the management of refractory and super-refractory status epilepticus: a systematic review.
    Dozières-Puyravel B; Höhn S; Auvin S
    Expert Rev Neurother; 2021 Nov; 21(11):1303-1308. PubMed ID: 34275391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocilizumab in pediatric refractory status epilepticus and acute epilepsy: Experience in two patients.
    Cantarín-Extremera V; Jiménez-Legido M; Duat-Rodríguez A; García-Fernández M; Ortiz-Cabrera NV; Ruiz-Falcó-Rojas ML; González-Gutiérrez-Solana L
    J Neuroimmunol; 2020 Mar; 340():577142. PubMed ID: 31935626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.